Oncotelic Therapeutics Inc (OTLC) earnings · P/E 0.1, rev $250.0K
Oncotelic Therapeutics Inc (OTLC) is a biotechnology company listed on OTCQB.
This OTLC earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported OTLC revenue for 2026-06-30 was $250.0K. Net income was -$1.8M. OTLC currently screens at market cap $17.8M and trailing P/E 0.1.
When the next OTLC 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for OTLC. We will not invent a beat or miss.
Not investment advice. Full OTLC research stays on the stock page; the tape stays on the quote page.
Not investment advice.